Kratz H J, Borsos T, Isliker H
Ann Inst Pasteur Immunol (1985). 1985 Sep-Oct;136D(2):98-103.
Sheep erythrocytes were coupled with trinitophenyl sulphonate, sensitized with anti-TNP (or-DNP) IgM monoclonal antibodies, and exposed to components of the classical pathway of complement activation. When human fibronectin (FN) was added after C1q, but before addition of C1r and C1s (subunits of the first complement component), inhibition of haemolytic activity was observed which was strictly dependent upon the dose of FN. When FN was added after addition of C1 (reconstituted from C1q, C1r and C1s), the haemolytic activity of complement was not affected by the presence of FN. These data suggest that FN binds on C1q by interfering with C1r and C1s fixation. In addition, FN was unable to displace the activated subcomponents (C1r and C1s) from their binding site on C1q. When using other systems (sheep erythrocytes sensitized with anti-Forssman IgM monoclonal antibodies), the quantity of FN required to inhibit complement haemolytic activity was greater than in the TNP system. In normal plasma, there is a 50-fold excess of FN compared to free C1q.
绵羊红细胞与三硝基苯磺酸盐偶联,用抗 - TNP(或 - DNP)IgM单克隆抗体致敏,并暴露于补体激活经典途径的成分中。当在C1q之后但在添加C1r和C1s(第一补体成分的亚基)之前加入人纤连蛋白(FN)时,观察到溶血活性受到抑制,且这种抑制严格依赖于FN的剂量。当在添加C1(由C1q、C1r和C1s重构而成)之后加入FN时,补体的溶血活性不受FN存在的影响。这些数据表明FN通过干扰C1r和C1s的固定而结合在C1q上。此外,FN无法将活化的亚成分(C1r和C1s)从它们在C1q上的结合位点置换下来。当使用其他系统(用抗福斯曼IgM单克隆抗体致敏的绵羊红细胞)时,抑制补体溶血活性所需的FN量比在TNP系统中更多。在正常血浆中,FN的量比游离C1q多50倍。